FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy
Related Topics >> Cephalon | FDA delay | Nuvigil

FDA hesitates on Cephalon's jet lag drug

December 22, 2009 — 10:32am ET | By Maureen Martino
Tools

The FDA has delayed approval of Cephalon's Nuvigil for jet lag by three months, saying it needs more time to review the company's application before it can approve an additional indication. Nuvigil is already approved as a treatment for sleep disorders. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Comments (1) | Post a comment
More stories about Cephalon   FDA delay   Nuvigil  

Comments

By Anonymous | Posted 2:57pm | January 10, 2010

Nuvigil, if approved by the FDA, will be great for the company Cephalon, but will it be good for the traveling public? As a physician, I'm skeptical. Many safer alternatives available. I'm not ready to prescribe it or to take it. See http://bit.ly/7iZqB1

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.